Literature DB >> 22737417

Serum levels of interleukin 10 (IL-10) in patients with type 2 diabetes.

N Yaghini1, M Mahmoodi, Gh R Asadikaram, Gh H Hassanshahi, H Khoramdelazad, M Kazemi Arababadi.   

Abstract

Entities:  

Keywords:  Interleukin 10; Type 2 diabetes

Year:  2011        PMID： 22737417      PMCID： PMC3371882     

Source DB:  PubMed          Journal:  Iran Red Crescent Med J        ISSN： 2074-1804            Impact factor:   0.611


× No keyword cloud information.
  10 in total

1.  Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory.

Authors:  Annapaula Giulietti; Evelyne van Etten; Lut Overbergh; Katinka Stoffels; Roger Bouillon; Chantal Mathieu
Journal:  Diabetes Res Clin Pract       Date:  2006-11-16       Impact factor: 5.602

2.  T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos Araya; Leila Diaz; Clive Wasserfall; Mark Atkinson; Wei Mu; Richard Johnson; Eduardo Garin
Journal:  Pediatr Nephrol       Date:  2009-06-03       Impact factor: 3.714

3.  The interleukin-10 levels as a potential indicator of positive response to interferon beta treatment of multiple sclerosis patients.

Authors:  Halina Bartosik-Psujek; Zbigniew Stelmasiak
Journal:  Clin Neurol Neurosurg       Date:  2005-12-15       Impact factor: 1.876

4.  Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study.

Authors:  Eric van Exel; Jacobijn Gussekloo; Anton J M de Craen; Marijke Frölich; Annetje Bootsma-Van Der Wiel; Rudi G J Westendorp
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

5.  Interleukin-10 plasmid construction and delivery for the prevention of type 1 diabetes.

Authors:  Minhyung Lee; Hyewon Park; Jeehee Youn; Eun Taex Oh; Kyungsoo Ko; Sungwan Kim; Yongsoo Park
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

6.  Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome.

Authors:  Ching-Yuang Lin; Jien-Wen Chien
Journal:  Acta Paediatr Taiwan       Date:  2004 Mar-Apr

7.  IL-12 p40 homodimer, but not IL-12 p70, induces the expression of IL-16 in microglia and macrophages.

Authors:  Malabendu Jana; Kalipada Pahan
Journal:  Mol Immunol       Date:  2008-12-18       Impact factor: 4.407

Review 8.  Pathogenesis of kidney disease in systemic lupus erythematosus.

Authors:  Harini Bagavant; Shu Man Fu
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

Review 9.  Conference on "Multidisciplinary approaches to nutritional problems". Symposium on "Diabetes and health". Nutrition interventions for the prevention of type 2 diabetes.

Authors:  Nelia P Steyn; Estelle V Lambert; Hanani Tabana
Journal:  Proc Nutr Soc       Date:  2008-12-10       Impact factor: 6.297

10.  IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.

Authors:  Małgorzata Wegner; Hanna Winiarska; Teresa Bobkiewicz-Kozłowska; Marzena Dworacka
Journal:  Cytokine       Date:  2008-04-07       Impact factor: 3.861
  10 in total
  20 in total

1.  Changes of Th17 cells, regulatory T cells, Treg/Th17, IL-17 and IL-10 in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Changyan Zi; Lisha He; Huan Yao; Yuan Ren; Tingting He; Yongxiang Gao
Journal:  Endocrine       Date:  2022-04-09       Impact factor: 3.633

2.  IL-10 Dysregulation Underlies Chemokine Insufficiency, Delayed Macrophage Response, and Impaired Healing in Diabetic Wounds.

Authors:  Ruchi Roy; Janet Zayas; Mohamed F Mohamed; Anahita Aboonabi; Kaylee Delgado; Jennillee Wallace; Mohammad Bayat; Timothy M Kuzel; Jochen Reiser; Sasha H Shafikhani
Journal:  J Invest Dermatol       Date:  2021-09-10       Impact factor: 7.590

3.  The Promising Role of Microbiome Therapy on Biomarkers of Inflammation and Oxidative Stress in Type 2 Diabetes: A Systematic and Narrative Review.

Authors:  Pradipta Paul; Ridhima Kaul; Basma Abdellatif; Maryam Arabi; Rohit Upadhyay; Reya Saliba; Majda Sebah; Ali Chaari
Journal:  Front Nutr       Date:  2022-05-25

Review 4.  Is the CCR5 Δ 32 mutation associated with immune system-related diseases?

Authors:  Khodayar Ghorban; Maryam Dadmanesh; Gholamhossein Hassanshahi; Mohammad Momeni; Mohammad Zare-Bidaki; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

Review 5.  Is the IL-10 promoter polymorphism at position -592 associated with immune system-related diseases?

Authors:  Mojgan Noroozi Karimabad; Mohammad Kazemi Arababadi; Elham Hakimizadeh; Hassan Yousefi Daredori; Mahmood Nazari; Gholamhossein Hassanshahi; Derek Kennedy
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

Review 6.  Significance of CXCL12 in type 2 diabetes mellitus and its associated complications.

Authors:  Mojgan Noroozi Karimabad; Gholamhossein Hassanshahi
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

Review 7.  The interrelation of osteoarthritis and diabetes mellitus: considering the potential role of interleukin-10 and in vitro models for further analysis.

Authors:  Silke Schwarz; Ingo Mrosewski; Sandeep Silawal; Gundula Schulze-Tanzil
Journal:  Inflamm Res       Date:  2017-12-01       Impact factor: 4.575

Review 8.  An association between IL-10 promoter polymorphisms and diabetic nephropathy: a meta-analysis of case-control studies.

Authors:  Norah Htet Htet; Arun Kumar Basavaraj; Cho Naing; Sivalingam Nalliah
Journal:  J Diabetes Metab Disord       Date:  2018-09-01

9.  Hyperglycaemia cause vascular inflammation through advanced glycation end products/early growth response-1 axis in gestational diabetes mellitus.

Authors:  Barathi Rajaraman; Nirupama Ramadas; Sundar Krishnasamy; Vidya Ravi; Atima Pathak; C S Devasena; Krishnan Swaminathan; Arunkumar Ganeshprasad; Ashok Ayyappa Kuppuswamy; Srinivasan Vedantham
Journal:  Mol Cell Biochem       Date:  2019-02-14       Impact factor: 3.396

10.  Five-year assessment of time of sputum smears conversion and outcome and risk factors of tuberculosis patients in central iran.

Authors:  Fatemah Behnaz; Mahmoud Mohammadzadeh; Golnaz Mohammadzade
Journal:  Tuberc Res Treat       Date:  2015-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.